Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 0.00%, near the low end of its 5-year range (0.00%–187.03%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 13.82%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
13.82%
DEBT TO ASSETS RATIO AVG 3Y
0.00%
DEBT TO ASSETS RATIO AVG 5Y
0.00%
DEBT TO ASSETS RATIO AVG 10Y
0.79%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 663 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Minerva Neurosciences, Inc.
Market Cap
$156.07M
Debt to Assets Ratio
0.00%
TTM Avg
13.82%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$156.62M
Debt to Assets Ratio
0.89%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$154.46M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$154.07M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$151.52M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$149.87M
Debt to Assets Ratio
0.27%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $156.07M | 0.00% | 13.82% | 0.00% | 0.00% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $156.62M | 0.89% | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $156.90M | 0.06% | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $154.46M | 0.00% | N/A | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $154.07M | 0.06% | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $152.20M | 0.60% | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $151.52M | 0.00% | N/A | N/A | N/A |
| PepGen Inc. (PEPG)vs › | $162.20M | 0.11% | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $149.87M | 0.27% | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | 0.10% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
N/A
Current Ratio
20.14
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 69.09% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 187.03% |
| 2024-03-31 | 166.83% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 107.66% |
| 2022-03-31 | 96.44% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.02% |
| 2021-03-31 | 0.06% |
| 2020-12-31 | 0.19% |
| 2020-09-30 | 0.24% |
| 2020-06-30 | 0.30% |
| 2020-03-31 | 0.35% |
| 2019-12-31 | 0.37% |
| 2019-09-30 | 0.29% |
| 2019-06-30 | 0.30% |
| 2019-03-31 | 0.31% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.87% |
| 2018-03-31 | 1.55% |
| 2017-12-31 | 2.16% |
| 2017-09-30 | 2.68% |
| 2017-06-30 | 5.02% |
| 2017-03-31 | 5.59% |
| 2016-12-31 | 6.54% |
| 2016-09-30 | 6.91% |
| 2016-06-30 | 6.90% |
| 2016-03-31 | 10.61% |
| 2015-12-31 | 12.03% |
| 2015-09-30 | 11.04% |
| 2015-06-30 | 10.37% |
| 2015-03-31 | 9.53% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 6.40% |
| 2014-03-31 | 1.57% |
| 2013-12-31 | 0.20% |
